Wikidata

(Q64611789)

English

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.

clinical trial

In more languages

Statements

title
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction. (English)
0 references
country
Australia
0 references
Austria
0 references
Bulgaria
0 references
Canada
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
August 2014
0 references
end time
December 2015
0 references
number of participants
1,267
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64611789&oldid=1857789387"